FDA Approves New Therapy for Myelodysplastic Syndromes, Rare Form of Blood Cancers
THE BAJA POSTNEWSROOM The U.S. Food and Drug Administration approved Tibsovo (ivosidenib) for the treatment of adult patients with relapsed or refractory (R/R) cancers called myelodysplastic syndromes …